Nanotechnology in medicine – our experiences-Reference-Cited by-同舟云学术

Nanotechnology in medicine – our experiences

Published:2022-12-31 Issue:03 Volume:68 Page:21-22
ISSN:1857-8969
Container-title:Macedonian Pharmaceutical Bulletin
language:en
Short-container-title:Maced. Pharm. Bull.

Author:

Geskovski Nikola¹,Mraiche Fatima²,C. Yalcin Huseyin²,Gorachinov Filip¹,A. Moustafa Diala³,Dimchevska Simona⁴,Glavas Dodov Marija¹,Simonoska Crcarevska Maja¹,Goracinova Katerina¹

Affiliation:

1. Faculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, Majka Tereza 47, 1000 Skopje, North Macedonia

2. College of Pharmacy, Qatar University, 4Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University

3. College of Pharmacy, Qatar Universit

4. Brandenburg University of Technology Cottbus – Senftenberg, Germany

Publisher

Macedonian Pharmaceutical Association

Subject

General Medicine

Link

http://bulletin.mfd.org.mk/volumes/Volume%2068_3/68_3_007.pdf

Reference6 articles.

1. Al-Thani, et al., 2022. Reduced Cardiotoxicity of Ponatinib-Loaded PLGA-PEG-PLGA Nanoparticles in Zebrafish Xenograft Model. Materials 15(11), 3960. https://doi.org/10.3390/MA15113960

2. Dimchevska, S., et al., 2017. Efficacy assessment of self-assembled PLGA-PEG-PLGA nanoparticles: Correlation of nano-bio interface interactions, biodistribution, internalization and gene expression studies. Int. J. Pharm. 533(2), 389–401. https://doi.org/10.1016/j.ijpharm.2017.05.05

3. Goracinova, K., et al., 2018. Design of Nanostructures for Theranostics Applications Elsevier, pp. 109–160. https://doi.org/10.1016/B978-0-12-813669-0.00004-X

4. Geskovski, N. Rational design of biopharmaceutical properties of nanodrug delivery systems, PhD Thesis 2015.

5. Koliqi, R., et al., 2016. PEO-PPO-EO/Poly(DLLA-CL) Nanoparticles as Carriers for SN-38: Design, Optimization and Nano-Bio Interface Interactions. Curr. Drug Del. 13(3), 339–352. https://doi.org/10.2174/1567201813666151130221806